NCT01384396View on ClinicalTrials.gov

A Clinical Study of KW-3357 in Patients With DIC

PHASE3CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

April 30, 2013

Study Completion Date

April 30, 2013

Conditions
Disseminated Intravascular Coagulation (DIC)
Interventions
DRUG

KW-3357

Intravenous infusion once a day

Trial Locations (1)

Unknown

Kanazawa

All Listed Sponsors
lead

Kyowa Kirin Co., Ltd.

INDUSTRY

NCT01384396 - A Clinical Study of KW-3357 in Patients With DIC | Biotech Hunter | Biotech Hunter